The following new disclosure will be required in companies’ upcoming Forms 10-K (FY 2024) and/or proxy statements: Assess whether any updates to the policy are necessary before the issuer’s next 10-K ...

Ostin Technology Group Co., Ltd. (the “Company”) (Nasdaq: OST), a supplier of display modules and polarizers in China, today announced that its digital photo frame and display product, Pintura, has ...

Asian stock markets traded mostly lower on Thursday, taking mixed cues from Wall Street amid persistent uncertainty over ...

PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announced that Bharatt Chowrira ...

In the past, Alibaba (NYSE: BABA) was often viewed as the Amazon (NASDAQ: AMZN) of China. While Amazon's stock is up more ...

Ostin Technology Group Co., Ltd. (the "Company") (Nasdaq: OST), a supplier of display modules and polarizers in China, today announced that its digital ...

Ceragon , a leading solutions provider of end-to-end wireless connectivity, today announced that management will participate at the 27th Annual Needham Growth Conference in New York City.     Doron ...

Enanta Pharmaceuticals, Inc. , a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that Jay R. Luly, Ph.D., ...

Bio-Techne Corporation today announced it will showcase its new ProPaktm GMP cytokines, alongside its portfolio of innovative products and solutions supporting cell and gene therapy development and ...

Mr. Kalir brings a wealth of experience as an investor, entrepreneur, and thought leader with a deep focus on life sciences and technology. Currently the Managing Member of Martial Eagle Fund and a ...

I-Mab (the "Company"), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced the Company has been informed ...

Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the initiation of ...